- The report added that earlier in the day, the Nikkei business daily said Carlyle’s investment is expected to be about 100 billion yen ($972.9 million)
- Rigaku provides X-ray analysis, measurement and testing instruments for a wide-ranging industries including semiconductor manufacturing and pharmaceuticals
As per a report by Reuters, U.S. buyout firm Carlyle Group said that it will buy Japan’s Rigaku Corp, confirming a media report from earlier in the day that put the deal value at about $1 billion. This happens as the manufacturer of X-ray-based testing tools plans to go public.
The report added that if a deal comes through, it could be the first investment of Carlyle Group’s new Japan-focused buyout fund worth 258 billion yen ($2.5 billion), its fourth and biggest to date. It added that Carlyle will own about 80 per cent of Rigaku and 20 per cent stake will remain with the chief executive officer of Rigaku, as per a statement by Carlyle Group. It did not provide details of the deal value.
Carlyle’s investment is expected to be about 100 billion yen ($972.9 million)
The report added that earlier in the day, the Nikkei business daily said Carlyle’s investment is expected to be about 100 billion yen ($972.9 million). Rigaku provides X-ray analysis, measurement and testing instruments for a wide-ranging industries including semiconductor manufacturing and pharmaceuticals.
The report added that by teaming up with Carlyle, Rigaku “will seek to list the holding company in the coming years,” as per what the Japanese company said in a separate statement. It added that its annual revenue stands at about 44 billion yen, around two-thirds of which were generated overseas.
